Fred Hutch study discovers rare set of cells that are highly effective at fighting cancer
Saturday, March 4, 2017
The discovery and the new tech will be important for scientists developing CAR-T immunotherapies, treatments that reprogram a person’s T-cells to fight cancer.
The tech was developed by Seattle-based Adaptive Biotechnologies, and it assigns a “barcode” to each T-cell based on the kind of T-cell receptor (TCR) it has. This allows researchers to track different kinds of T-cells in the lab and in patients’ bodies.